This finding indicated that the mAb MDR1-NPs, which specifically bound to the MDR1 receptor, had overexpressed at the drug-resistant cell surface and prevented gefitinib (a hydrophobic drug) from efflux outside the cells, thus improving the drug concentration at the tumor site. Here, ABCB1 is linked to neoplasm.